the co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression a preliminary trial喹硫平或安慰剂的合并施打将认知-行为疗法在治疗难治性抑郁症的初步试验.pdf

BMC Psychiatry BioMed Central Research article Open Access The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial 1,2,5 3 4 Yves Chaput* , Annick Magnan and Alain Gendron 1 2 Address: Associate Professor of Psychiatry, McGill University Montreal, Quebec, Canada, Assistant Professor of Psychiatry, University of Montreal, Montreal, Quebec, Canada, 3 Centre de Psychologie René Laënnec, 1100, Beaumont Ave, Montreal, Quebec, H3P 3H5, Canada, 4Neurosciences, Medical Affairs, AstraZeneca Canada Mississauga, Ontario, Canada and 5Current address: 365 rue Normand, suite 230, Saint-Jean- sur-Richelieu, Quebec, J3A 1T6, Canada Email: Yves Chaput* - yveschaput@bellnet.ca; Annick Magnan - annickmagnan@videotron.ca; Alain Gendron - alaingendron@astrazeneca.ca * Corresponding author Published: 28 August 2008 Received: 7 November 2007 Accepted: 28 August 2008 BMC Psychiatry 2008, 8:73 doi:10.1186/1471-244X-8-73 This article is available from: /1471-244X/8/73 © 2008 Chaput et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Patients with major depression